Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
1(10%)
Results Posted
22%(2 trials)

Phase Distribution

Ph phase_4
1
10%
Ph not_applicable
8
80%
Ph phase_1
1
10%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
8(80.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(9)

Detailed Status

Completed9
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (10.0%)
Phase 41 (10.0%)
N/A8 (80.0%)

Trials by Status

recruiting110%
completed990%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
10